Cell therapies are an emerging and exciting space in the biotech world, with the potential to positively impact patient lives all over the world. Many cell therapy companies are currently working on novel therapeutics for previously untreatable diseases and cancers. Cell therapy also has the potential to restore the function of a gene over time and may allow patients to manage diseases without the need for ongoing treatment. We are at a development tipping point, with some of the first cell therapies becoming commercially available on the market and many more in the research and clinical pipeline.

Related Resources
All Resources

post
Oral Drug Product Development of Small Molecules
Read More

white-paper
The New Chemistry, Manufacturing, and Controls (CMC) Regulations in China
Read More

post
Why FDA PreCheck is a game-changer for small & mid-sized pharma — and how these companies should lean in
Read More

white-paper
Solid-Phase Oligonucleotide Synthesis (SPOS) and Liquid-Phase Oligonucleotide Synthesis (LPOS): Complementary or Competitive Processes?
Read More
Let's move from science to success.
Let’s Talk
